COVID-19, influenza, and respiratory syncytial virus vaccination coverage is low among adults so far this respiratory virus season (2024 to 2025).

Seasonal maternal respiratory syncytial virus vaccination and nirsevimab for infants demonstrate cost-effectiveness.

RSV remains a major cause of hospitalization among children, according to a population-based Canadian Immunization Research ...

Effectiveness of Maternal Vaccination to Prevent Respiratory Syncytial Virus Illness,” published in the November 2024 issue ...

So far very few Americans have been rolling up their sleeves to get vaccinated against COVID, flu or RSV. Rob Stein is a correspondent and senior editor on NPR's science desk.

"Flu tends to impact us a little later in the year, or early into the new year, so that at this point in time for any of the ...

COLUMBIA - The start of winter is less than a month away, and as temperatures continue to decline cases of the flu and ...

Three scientists received the Tata Transformation Prize for innovations in sustainable energy, nutrition, and a low-cost RSV vaccine, each winning ₹2 crore ...

A live virus vaccine contains a live, weakened (attenuated) virus that helps your body develop an immune response without you developing symptoms of the disease it is intended to prevent. Examples ...

Significant gaps in vaccination coverage among nursing home residents leaves vulnerable populations at risk for severe ...